Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Anti-inflammatory mechanisms of neovestitol from Brazilian red propolis in LPS-activated macrophages

Full text
Author(s):
Bueno-Silva, Bruno ; Rosalen, Pedro L. ; Alencar, Severino M. ; Mayer, Marcia P. A.
Total Authors: 4
Document type: Journal article
Source: Journal of Functional Foods; v. 36, p. 440-447, SEP 2017.
Web of Science Citations: 6
Abstract

Neovestitol is considered one of the main bioactive components of Brazilian red propolis. Neovestitol's antimicrobial and antioxidant effects have already been demonstrated. Here, neovestitol immune modulatory effects were investigated on LPS activated macrophages. RAW264.7 murine macrophages activated with LPS were treated with neovestitol and NO production, cell viability and cytokines profile were determined. Activation of inflammatory signaling pathways and macrophage polarization were determined by RT-qPCR and Western blot. Neovestitol at 0.22 mu M inhibited NO production by 60% without affecting cell viability and reduced GM-CSF, IFN-gamma, IL-1 beta, IL-4, TNF-alpha and IL-6 levels, whereas increased IL-10 production. These cytokines profile changes were associated with the downregulation of transcription of genes involved in nitric oxide production, NF-KB, IL-1 beta, and TNF-alpha signaling pathways. NF-KB and MAPK signaling pathways inhibition and decreased levels of TIRAP were further confirmed by Western blot. Neovestitol, as a nutraceutical, is a potential candidate to modulate chronic inflammation in humans. (C) 2017 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 12/01500-4 - Assessment of effects of propolis and its bioactive compounds on the modulation of of macrophages inflammatory response
Grantee:Bruno Bueno Silva
Support type: Scholarships in Brazil - Post-Doctorate
FAPESP's process: 12/14323-3 - Assessment of effects of propolis and its bioactive compounds on the modulation of of macrophages inflammatory response
Grantee:Marcia Pinto Alves Mayer
Support type: Regular Research Grants